ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Allergy Therapeutics Plc

Allergy Therapeutics Plc is an active company incorporated on 1 June 2004 with the registered office located in Worthing, West Sussex. Allergy Therapeutics Plc was registered 21 years ago.
Status
Active
Active since incorporation
Company No
05141592
Public limited company
Age
21 years
Incorporated 1 June 2004
Size
Large
Turnover is over £54M
Over 250 employees
Confirmation
Submitted
Dated 22 September 2025 (3 months ago)
Next confirmation dated 22 September 2026
Due by 6 October 2026 (9 months remaining)
Last change occurred 3 years ago
Accounts
Due Soon
For period 1 Jul30 Jun 2024 (1 year)
Accounts type is Group
Next accounts for period 30 June 2025
Due by 31 December 2025 (8 days remaining)
Address
Dominion Way
Worthing
West Sussex
BN14 8SA
Address changed on 16 Nov 2025 (1 month ago)
Previous address was Link Group, Central Square, 29 Wellington Street Leeds LS1 4DL England
Telephone
01903844700
Email
Unreported
People
Officers
9
Shareholders
1
Controllers (PSC)
2
Director • British • Lives in England • Born in Nov 1950
Director • Physician • American,nigerian • Lives in United States • Born in Aug 1956
Director • Executive Director, Chief Financial Offi • British • Lives in England • Born in Jan 1976
Director • Canadian • Lives in England • Born in Mar 1968
Director • Hong Konger • Lives in Hong Kong • Born in Oct 1979
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Allergy Therapeutics (UK) Limited
Shaun Antony Furlong and Manuel Llobet are mutual people.
Active
Allergy Therapeutics (Holdings) Limited
Shaun Antony Furlong and Manuel Llobet are mutual people.
Active
Argonaute Rna Limited
David William Dawson Ball and Anthony Michael Parker are mutual people.
Active
Bristol Bluegreen Limited
Anthony Michael Parker is a mutual person.
Active
Beagle Partners LLP
Anthony Michael Parker is a mutual person.
Active
Brands
Allergy Therapeutics Plc
Allergy Therapeutics PLC is an immunology business that focuses on the research and development of allergy treatments..
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Jun 2024
For period 30 Jun30 Jun 2024
Traded for 12 months
Cash in Bank
£12.92M
Decreased by £1.93M (-13%)
Turnover
£55.2M
Decreased by £4.39M (-7%)
Employees
602
Decreased by 33 (-5%)
Total Assets
£64.83M
Decreased by £1.94M (-3%)
Total Liabilities
-£61.12M
Decreased by £3.59M (-6%)
Net Assets
£3.71M
Increased by £1.64M (+80%)
Debt Ratio (%)
94%
Decreased by 2.63% (-3%)
Latest Activity
Inspection Address Changed
1 Month Ago on 16 Nov 2025
Confirmation Submitted
2 Months Ago on 9 Oct 2025
Own Shares Purchased
10 Months Ago on 11 Feb 2025
Shares Cancelled
10 Months Ago on 11 Feb 2025
Group Accounts Submitted
1 Year Ago on 19 Dec 2024
Charge Satisfied
1 Year 1 Month Ago on 24 Oct 2024
Charge Satisfied
1 Year 1 Month Ago on 24 Oct 2024
Inspection Address Changed
1 Year 2 Months Ago on 16 Oct 2024
New Charge Registered
1 Year 2 Months Ago on 15 Oct 2024
Manuel Llobet Details Changed
16 Years Ago on 1 Jul 2009
Get Credit Report
Discover Allergy Therapeutics Plc's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Manuel Llobet on 1 July 2009
Submitted on 20 Nov 2025
Register inspection address has been changed from Link Group, Central Square, 29 Wellington Street Leeds LS1 4DL England to Mufg Corporate Markets Central Square Wellington Street Leeds LS1 4DL
Submitted on 16 Nov 2025
Statement of capital following an allotment of shares on 30 October 2025
Submitted on 12 Nov 2025
Confirmation statement made on 22 September 2025 with no updates
Submitted on 9 Oct 2025
Second filing for the appointment of Mr Anthony Michael Parker as a director
Submitted on 7 Mar 2025
Memorandum and Articles of Association
Submitted on 5 Mar 2025
Cancellation of shares. Statement of capital on 21 January 2025
Submitted on 11 Feb 2025
Purchase of own shares.
Submitted on 11 Feb 2025
Second filing of a statement of capital following an allotment of shares on 21 January 2025
Submitted on 5 Feb 2025
Statement of capital following an allotment of shares on 21 January 2025
Submitted on 4 Feb 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year